UK may become the first country to take Pfizer’s COVID-19 vaccine

UK may become the first country to take Pfizer’s COVID-19 vaccine. According to Bloomberg News, among many countries anxiously waiting for the protection of the COVID-19 vaccine, the United Kingdom may be the first to approve Pfizer and BioNTech vaccines.  The vaccine may be approved this week as reported.

The United Kingdom issued a statement very early stating that the United Kingdom will continue to rapidly promote any kind of successful vaccine research and development approval work, and hope that a vaccine will be on the market before Christmas. The UK’s drug and healthcare product regulatory agencies are accelerating their review of actions. The UK government has also invoked special rules to allow drug regulation to bypass EU institutions as the country prepares for the transitional period of Brexit.

In an interview with the BBC, British Foreign Secretary Dominic Raab said that we hope to market the vaccine before Christmas, and fully promote and distribute it in the spring, so that life can return to an almost normal level, and important progress has been made in dealing with various things.

In early November, the British drug and health products regulatory agency stated that it was evaluating whether Pfizer vaccines meet safety standards and ensuring that decisions are made in the shortest possible time without compromising the authority of the review. According to current Pfizer data, in the clinical trials of 44,000 people, the effective rate of vaccination prevention is 95%, so far there are no significant safety issues. But when the review was passed, the British drug and health care product regulatory agency refused to answer. Pfizer also said that it would not have more guesses about the review time and end time.

At present, the United Kingdom has ordered enough doses for 20 million injections from Pfizer. Of course, this will not happen immediately, because Pfizer has also signed hundreds of millions of doses with Europe, the United States, Japan and other countries. In addition, the United Kingdom has ordered 7 million doses of vaccine from Moderna for distribution.

Peter Openshaw, a professor of experimental medicine at Imperial College London and a government consultant, said that regulators are working very hard to study and review all the data. The vaccine may be announced within the next two weeks, or even next week. This is a very pleasant news, and we must wait and see.

(source:internet)